サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1591394

ファーマコビジランスと医薬品安全性ソフトウェア市場規模・予測、世界・地域別シェア、動向、成長機会分析レポート：提供別、展開別、企業規模別、形態別、機能別、エンドユーザー別、地域別

Pharmacovigilance and Drug Safety Software Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offering, Deployment, Enterprise Size, Form, Functionality, End User, and Geography

出版日
ページ情報
英文 388 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ファーマコビジランスと医薬品安全性ソフトウェア市場規模・予測、世界・地域別シェア、動向、成長機会分析レポート：提供別、展開別、企業規模別、形態別、機能別、エンドユーザー別、地域別
出版日: 2024年10月25日
発行: The Insight Partners
ページ情報: 英文 388 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ファーマコビジランスと医薬品安全性ソフトウェア市場規模は、2023年に2億1,439万米ドルと評価され、2031年には3億5,931万米ドルに達すると予測され、2023年から2031年までのCAGRは6.7%を記録すると推定されます。

ファーマコビジランスと医薬品安全性ソフトウェア市場は、北米、欧州、アジア太平洋（APAC）、中東・アフリカ（MEA）、中南米の主要5地域に区分されます。2023年の市場規模は北米が圧倒的に大きく、次いで欧州、アジア太平洋の順となっています。北米のファーマコビジランスと医薬品安全性ソフトウェア市場は、米国、カナダ、メキシコに区分されます。北米は、ファーマコビジランスと医薬品安全性ソフトウェアの進歩に継続的に取り組んでいるIQVIA Oracle Corporationのような様々な市場企業の存在により、ファーマコビジランスと医薬品安全性ソフトウェア市場で驚異的な成長を示しています。2024年7月、オラクル・コーポレーションはAIベースのOracle ArgusプラットフォームをSafety One Intakeソリューションとして発表しました。このソリューションは、ライフサイエンス企業が拡大する規制要件を満たし、増加する有害事象事例を軽減するのに役立ちます。この新しいファーマコビジランス・プラットフォームは、生産性の向上、データ・プライバシーの改善、報告の強化を目的としています。したがって、この地域の市場企業によるこのような製品革新は、この地域におけるファーマコビジランスと医薬品安全性ソフトウェア市場の成長を促進しています。

アジア太平洋地域は、インド、中国、日本、韓国、オーストラリア、その他アジア太平洋地域など、さまざまな成長経済圏で構成されています。アジア太平洋地域では、ヘルスケア分野のデジタル化が進んでいます。同地域の各国政府は、ヘルスケアシステムを強化し、デジタル化するためにさまざまな取り組みを行っています。例えば、中国の公務員医療費は2023年に3,185億米ドルに達しました。インド・ブランド・エクイティ財団によると、インドのヘルスケア産業は2023年に3,720億米ドルと評価され、公共部門と民間部門の両方が牽引しています。アジア太平洋諸国全体でこのような医療支出の増加は、予測期間中にファーマコビジランスと医薬品安全性ソフトウェア市場の成長のための大規模な需要を生み出しています。

企業規模に基づいて、世界のファーマコビジランスと医薬品安全性ソフトウェア市場は中小企業と大企業に二分されます。大企業によるファーマコビジランス・ソフトウェアへの投資が増加していることから、2023年には大企業セグメントが企業規模別市場を独占しています。世界に事業を展開する大企業は、複数の地域のファーマコビジランス・ガイドラインを遵守しなければなりません。ファーマコビジランス・ソフトウェアは、世界な安全性データの統合と標準化を支援し、これらの組織が複数の地域で医薬品の安全性をリアルタイムで監視できるようにします。大規模な組織では、臨床試験中および市販後の両方で、大量の有害事象データを受け取ります。ファーマコビジランス・ソフトウェアは、これらの組織が増加するデータ量を効率的に管理・分析し、コンプライアンス違反や安全性シグナルの見逃しの可能性を低減するのに役立ちます。ファーマコビジランス・ソフトウェアは機密性の高い患者データを処理するため、大企業は欧州の一般データ保護規則（GDPR）などのデータ保護規制へのコンプライアンスを確保するため、堅牢なデータ・セキュリティとプライバシー機能を備えたソフトウェア・ソリューションを採用しています。

ArisEurope;ICON plc;Syneos Health;Accenture;IQVIA;Genpact;Cognizant;Paraxel International Corporation;Laboratory Corporation of America Holdings;Max Application;Clinevo Technologies;Qinecsa Solutions;AB Cube;and Veeva Systemsは、この市場調査で紹介されているファーマコビジランスと医薬品安全性ソフトウェア市場の主要企業です。

ファーマコビジランスと医薬品安全性ソフトウェアの市場規模は、一次情報および二次情報の両方を用いて算出されています。ファーマコビジランスと医薬品安全性ソフトウェアの市場規模に関連する定性的および定量的情報を得るために、社内外の情報源を用いて徹底的な二次調査を実施しました。このプロセスは、すべての市場セグメントに関する市場の概要と予測を得るのにも役立ちます。また、データを検証し分析的洞察を得るために、業界関係者に複数の一次インタビューを実施しています。このプロセスには、ファーマコビジランスと医薬品安全性ソフトウェア市場を専門とする副社長、市場開発マネージャー、マーケットインテリジェンスマネージャー、国内営業マネージャーなどの業界専門家と、評価専門家、研究アナリスト、キーオピニオンリーダーなどの外部コンサルタントが参加しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 市場の魅力

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の作成
    • データの三角測量
    • 国レベルのデータ

第4章 ファーマコビジランスと医薬品安全性ソフトウェア市場情勢

  • PEST分析
  • エコシステム分析
    • ソフトウェア／サービスプロバイダー
    • システムインテグレーター
    • 規制機関
    • エンドユーザー
    • バリューチェーンのベンダー一覧

第5章 ファーマコビジランスと医薬品安全性ソフトウェア市場- 主な市場力学

  • ファーマコビジランスと医薬品安全性ソフトウェア市場- 主な市場力学
  • 市場促進要因
    • 医薬品副作用の増加
    • ファーマコビジランスの世界化
    • 医薬品開発費の急増
  • 市場抑制要因
    • 高い設置費用とメンテナンス費用
  • 市場機会
    • AI、ML、NLPとソフトウェアの統合
  • 今後の動向
    • クラウドベースのファーマコビジランスと医薬品安全性ソフトウェア
  • 促進要因と抑制要因の影響

第6章 ファーマコビジランスと医薬品安全性ソフトウェア市場：世界市場分析

  • ファーマコビジランスと医薬品安全性ソフトウェアの市場収益、2021年～2031年
  • ファーマコビジランスと医薬品安全性ソフトウェア市場予測分析

第7章 ファーマコビジランスと医薬品安全性ソフトウェア市場分析- 提供別

  • ソフトウェア
  • サービス

第8章 ファーマコビジランスと医薬品安全性ソフトウェア市場分析-展開別

  • クラウド
  • オンプレミス

第9章 ファーマコビジランスと医薬品安全性ソフトウェアの市場分析-企業規模別

  • 大企業
  • 中小企業

第10章 ファーマコビジランスと医薬品安全性ソフトウェアの市場分析-形態別

  • 標準型
  • カスタマイズ

第11章 ファーマコビジランスと医薬品安全性ソフトウェアの市場分析-機能別

  • シグナルとリスク管理
  • 問題追跡と有害事象追跡
  • 症例管理
  • 臨床安全性管理および臨床試験安全性
  • 品質とコンプライアンス
  • メディカルライティング
  • 監査サポートとトレーニングコンプライアンス
  • ヘルスケア分析
  • その他

第12章 ファーマコビジランスと医薬品安全性ソフトウェアの市場分析-エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 受託研究機関
  • ビジネスプロセスアウトソーシング（BPO）企業
  • その他

第13章 ファーマコビジランスと医薬品安全性ソフトウェア市場- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • APACのその他諸国
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第14章 競合情勢

  • 主要企業によるヒートマップ分析
  • 企業のポジショニングと集中度

第15章 業界情勢

  • 市場イニシアティブ
  • 合併と買収

第16章 企業プロファイル

  • ArisGlobal LLC
  • Max Application
  • Oracle Corp
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • ICON Plc
  • Cognizant Technology Solutions Corp
  • Accenture Plc
  • Syneos Health Inc
  • Genpact Ltd.
  • AB Cube S.A.S.
  • Laboratory Corp of America Holdings
  • Parexel International Corp
  • Qinecsa Solutions
  • Clinevo Technologies

第17章 付録

図表

List Of Tables

  • Table 1. Pharmacovigilance and Drug Safety Software Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 4. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Offering
  • Table 5. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Deployment
  • Table 6. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Enterprise Size
  • Table 7. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Form
  • Table 8. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by Functionality
  • Table 9. Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 11. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 12. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 13. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 14. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 15. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 16. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 17. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 18. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 19. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 20. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 21. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 22. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 23. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 24. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 25. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 26. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 27. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 28. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 29. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 30. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 31. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 32. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 33. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 34. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 35. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 36. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 37. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 38. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 39. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 40. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 41. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 42. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 43. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 44. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 45. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 46. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 47. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 48. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 49. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 50. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 51. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 52. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 53. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 55. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 56. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 57. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 58. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 59. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 60. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 61. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 62. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 63. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 64. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 65. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 66. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 67. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 68. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 69. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 70. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 71. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 72. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 73. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 74. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 75. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 76. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 77. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 78. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 79. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 80. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 81. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 82. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 83. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 84. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 85. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 86. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 87. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 88. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 89. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 90. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 91. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 92. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 93. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 94. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 95. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 96. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 97. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 98. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 99. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 100. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 101. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 102. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 103. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 104. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 105. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 106. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 107. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 108. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 109. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 110. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 111. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 112. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 113. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 114. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 115. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 116. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 117. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 118. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 119. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 120. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 121. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 122. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 123. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 124. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 125. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 126. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 127. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 128. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 129. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 130. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 131. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 132. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 133. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 134. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 135. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 136. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 137. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 138. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 139. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 140. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 141. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 142. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 143. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 144. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 145. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 146. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 147. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 148. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 149. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 150. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 151. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 152. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 153. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 154. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 155. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 156. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 157. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 158. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 159. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 160. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 161. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 162. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 163. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 164. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 165. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 166. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 167. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 168. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 169. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 170. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 171. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 172. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Deployment
  • Table 173. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Enterprise Size
  • Table 174. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Form
  • Table 175. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by Functionality
  • Table 176. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 177. Company Positioning & Concentration
  • Table 178. List of Abbreviation

List Of Figures

  • Figure 1. Pharmacovigilance and Drug Safety Software Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021-2031
  • Figure 5. Pharmacovigilance and Drug Safety Software Market Share (%) - by Offering (2023 and 2031)
  • Figure 6. Software: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Services: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Pharmacovigilance and Drug Safety Software Market Share (%) - by Deployment (2023 and 2031)
  • Figure 9. Cloud: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. On Premises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Pharmacovigilance and Drug Safety Software Market Share (%) - by Enterprise Size (2023 and 2031)
  • Figure 12. Large Enterprises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. SMEs: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Pharmacovigilance and Drug Safety Software Market Share (%) - by Form (2023 and 2031)
  • Figure 15. Standard: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Customized: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Pharmacovigilance and Drug Safety Software Market Share (%) - by Functionality (2023 and 2031)
  • Figure 18. Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Case Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Quality and Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Medical Writing: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Pharmacovigilance and Drug Safety Software Market Share (%) - by End User (2023 and 2031)
  • Figure 28. Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Pharmacovigilance and Drug Safety Software Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 33. North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 35. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 36. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 37. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 38. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 39. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 40. North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 41. United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 46. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 47. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 48. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 49. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 50. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 51. Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 52. Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 58. Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 60. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 61. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 62. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 63. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 64. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 65. Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 66. China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 68. India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 69. South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 73. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 74. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 75. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 76. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 77. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 78. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 79. Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 80. Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 81. United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 82. South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 83. Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 84. South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 85. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering (2023 and 2031)
  • Figure 86. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment (2023 and 2031)
  • Figure 87. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size (2023 and 2031)
  • Figure 88. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form (2023 and 2031)
  • Figure 89. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality (2023 and 2031)
  • Figure 90. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User (2023 and 2031)
  • Figure 91. South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 92. Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 93. Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 94. Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 95. Heat Map Analysis by Key Players
目次
Product Code: TIPHC00002557

The pharmacovigilance and drug safety software market size was valued at US$ 214.39 million in 2023 and is expected to reach US$ 359.31 million by 2031; it is estimated to record a CAGR of 6.7% from 2023 to 2031.

The pharmacovigilance and drug safety software market is segmented into five major regions-North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2023, followed by Europe and Asia Pacific, respectively. The pharmacovigilance and drug safety software market in North America is segmented into the US, Canada, and Mexico. North America is witnessing tremendous growth in the pharmacovigilance and drug safety software market, owing to the presence of various market players such as IQVIA Oracle Corporation, who are continuously working on the advancement of pharmacovigilance and drug safety software. In July 2024, Oracle Corporation launched an AI-based Oracle Argus platform as a Safety One Intake solution. This solution helps life science organizations to meet growing regulatory requirements and to mitigate the rising volume of adverse event cases. This new pharmacovigilance platform aimed to increase productivity, improve data privacy, and enhance reporting. Thus, such product innovations by the market players in the region are fueling the growth of the pharmacovigilance and drug safety software market in the area.

Asia Pacific consists of various growing economies such as India, China, Japan, South Korea, Australia, and Rest of Asia Pacific. Asia Pacific is witnessing growing digitization in its healthcare sector. The governments of various countries in the region are taking different initiatives to enhance and digitize the healthcare system. For instance, China's healthcare expenditure of public financial officials reached US$ 318.5 billion in 2023. According to the India Brand Equity Foundation, the Indian Healthcare industry was valued at US$ 372 billion in 2023, driven by both the public and private sectors. Such rising healthcare expenditure across the Asia Pacific countries has created massive demand for the pharmacovigilance and drug safety software market growth during the forecast period.

Based on enterprise size, the global pharmacovigilance and drug safety software market is bifurcated into SMEs and large enterprises. The large enterprises segment dominated the market for enterprise size in 2023 owing to increasing investment by large companies in pharmacovigilance software. Large organizations with global operations must adhere to the pharmacovigilance guidelines of multiple regions. Pharmacovigilance software helps consolidate and standardize global safety data, ensuring that these organizations can monitor drug safety in real time across multiple geographies. Large organizations receive a high volume of adverse event data, both during clinical trials and post-marketing. Pharmacovigilance software helps these organizations manage and analyze the increasing data volume effectively, reducing the chances of noncompliance or missed safety signals. As pharmacovigilance software processes sensitive patient data, large organizations are adopting software solutions with robust data security and privacy features to ensure compliance with data protection regulations such as the General Data Protection Regulation (GDPR) in Europe.

ArisEurope; ICON plc; Syneos Health; Accenture; IQVIA; Genpact; Cognizant; Paraxel International Corporation; Laboratory Corporation of America Holdings; Max Application; Clinevo Technologies; Qinecsa Solutions; AB Cube; and Veeva Systems are among the key pharmacovigilance and drug safety software market players that are profiled in this market study.

The overall pharmacovigilance and drug safety software market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the pharmacovigilance and drug safety software market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the pharmacovigilance and drug safety software market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Pharmacovigilance and Drug Safety Software Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 Software/Service Providers:
    • 4.3.2 System Integrators:
    • 4.3.3 Regulatory Bodies:
    • 4.3.4 End-Users:
    • 4.3.5 List of Vendors in the Value Chain

5. Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

  • 5.1 Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rise in Incidences of Adverse Drug Reactions
    • 5.2.2 Globalization of Pharmacovigilance
    • 5.2.3 Surge in Drug Development Spending
  • 5.3 Market Restraints
    • 5.3.1 High Installation and Maintenance Costs
  • 5.4 Market Opportunities
    • 5.4.1 Integration of Software with AI, ML, and NLP
  • 5.5 Future Trends
    • 5.5.1 Cloud-Based Pharmacovigilance and Drug Safety Software:
  • 5.6 Impact of Drivers and Restraints:

6. Pharmacovigilance and Drug Safety Software Market - Global Market Analysis

  • 6.1 Pharmacovigilance and Drug Safety Software Market Revenue (US$ Million), 2021-2031
  • 6.2 Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Pharmacovigilance and Drug Safety Software Market Analysis - by Offering

  • 7.1 Software
    • 7.1.1 Overview
    • 7.1.2 Software: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Services
    • 7.2.1 Overview
    • 7.2.2 Services: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

8. Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment

  • 8.1 Cloud
    • 8.1.1 Overview
    • 8.1.2 Cloud: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 On Premises
    • 8.2.1 Overview
    • 8.2.2 On Premises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

9. Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size

  • 9.1 Large Enterprises
    • 9.1.1 Overview
    • 9.1.2 Large Enterprises: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 SMEs
    • 9.2.1 Overview
    • 9.2.2 SMEs: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

10. Pharmacovigilance and Drug Safety Software Market Analysis - by Form

  • 10.1 Standard
    • 10.1.1 Overview
    • 10.1.2 Standard: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Customized
    • 10.2.1 Overview
    • 10.2.2 Customized: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

11. Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality

  • 11.1 Signal and Risk Management
    • 11.1.1 Overview
    • 11.1.2 Signal and Risk Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Issue Tracking and Adverse Event Tracking
    • 11.2.1 Overview
    • 11.2.2 Issue Tracking and Adverse Event Tracking: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Case Management
    • 11.3.1 Overview
    • 11.3.2 Case Management: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Clinical Safety Management and Clinical Trial Safety
    • 11.4.1 Overview
    • 11.4.2 Clinical Safety Management and Clinical Trial Safety: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Quality and Compliance
    • 11.5.1 Overview
    • 11.5.2 Quality and Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.6 Medical Writing
    • 11.6.1 Overview
    • 11.6.2 Medical Writing: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.7 Audit Support and Training Compliance
    • 11.7.1 Overview
    • 11.7.2 Audit Support and Training Compliance: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.8 Healthcare Analytics
    • 11.8.1 Overview
    • 11.8.2 Healthcare Analytics: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.9 Others
    • 11.9.1 Overview
    • 11.9.2 Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

12. Pharmacovigilance and Drug Safety Software Market Analysis - by End User

  • 12.1 Pharmaceutical and Biotechnology Companies
    • 12.1.1 Overview
    • 12.1.2 Pharmaceutical and Biotechnology Companies: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.2 Contract Research Organizations
    • 12.2.1 Overview
    • 12.2.2 Contract Research Organizations: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.3 Business Process Outsourcing (BPO) Firms
    • 12.3.1 Overview
    • 12.3.2 Business Process Outsourcing (BPO) Firms: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
  • 12.4 Others
    • 12.4.1 Overview
    • 12.4.2 Others: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)

13. Pharmacovigilance and Drug Safety Software Market - Geographical Analysis

  • 13.1 Overview
  • 13.2 North America
    • 13.2.1 North America Pharmacovigilance and Drug Safety Software Market Overview
    • 13.2.2 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.2.3 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.2.3.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.2.4 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.2.4.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.2.5 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.2.5.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.2.6 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.2.6.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.2.7 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.2.7.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.2.8 North America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.2.8.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.2.9 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.2.9.1 North America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.2.9.2 United States: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.9.2.1 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.2.9.2.2 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.2.9.2.3 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.2.9.2.4 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.2.9.2.5 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.2.9.2.6 United States: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.2.9.3 Canada: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.9.3.1 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.2.9.3.2 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.2.9.3.3 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.2.9.3.4 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.2.9.3.5 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.2.9.3.6 Canada: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.2.9.4 Mexico: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.2.9.4.1 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.2.9.4.2 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.2.9.4.3 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.2.9.4.4 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.2.9.4.5 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.2.9.4.6 Mexico: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.3 Europe
    • 13.3.1 Europe Pharmacovigilance and Drug Safety Software Market Overview
    • 13.3.2 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.3.3 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.3.3.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.3.4 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.3.4.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.3.5 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.3.5.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.3.6 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.3.6.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.3.7 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.3.7.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.3.8 Europe: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.8.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.3.9 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.3.9.1 Europe: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.3.9.2 Germany: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.2.1 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.2.2 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.2.3 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.2.4 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.2.5 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.2.6 Germany: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.3 France: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.3.1 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.3.2 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.3.3 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.3.4 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.3.5 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.3.6 France: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.4.1 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.4.2 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.4.3 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.4.4 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.4.5 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.4.6 United Kingdom: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.5 Italy: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.5.1 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.5.2 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.5.3 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.5.4 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.5.5 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.5.6 Italy: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.6 Spain: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.6.1 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.6.2 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.6.3 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.6.4 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.6.5 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.6.6 Spain: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.3.9.7 Russia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.3.9.7.1 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.3.9.7.2 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.3.9.7.3 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.3.9.7.4 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.3.9.7.5 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.3.9.7.6 Russia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.4 Asia Pacific
    • 13.4.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Overview
    • 13.4.2 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.4.3 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.4.3.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.4.4 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.4.4.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.4.5 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.4.5.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.4.6 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.4.6.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.4.7 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.4.7.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.4.8 Asia Pacific: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.8.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.4.9 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.4.9.1 Asia Pacific: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.4.9.2 China: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.2.1 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.2.2 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.2.3 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.2.4 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.2.5 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.2.6 China: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.3 Japan: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.3.1 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.3.2 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.3.3 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.3.4 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.3.5 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.3.6 Japan: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.4 India: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.4.1 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.4.2 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.4.3 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.4.4 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.4.5 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.4.6 India: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.5 South Korea: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.5.1 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.5.2 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.5.3 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.5.4 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.5.5 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.5.6 South Korea: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.6 Australia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.6.1 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.6.2 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.6.3 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.6.4 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.6.5 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.6.6 Australia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.4.9.7 Rest of APAC: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.4.9.7.1 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.4.9.7.2 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.4.9.7.3 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.4.9.7.4 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.4.9.7.5 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.4.9.7.6 Rest of APAC: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.5 Middle East and Africa
    • 13.5.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Overview
    • 13.5.2 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.5.3 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.5.3.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.5.4 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.5.4.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.5.5 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.5.5.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.5.6 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.5.6.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.5.7 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.5.7.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.5.8 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.8.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.5.9 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.5.9.1 Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.5.9.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.2.1 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.2.2 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.2.3 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.2.4 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.2.5 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.2.6 Saudi Arabia: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.9.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.3.1 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.3.2 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.3.3 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.3.4 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.3.5 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.3.6 United Arab Emirates: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.9.4 South Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.4.1 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.4.2 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.4.3 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.4.4 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.4.5 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.4.6 South Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.5.9.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.5.9.5.1 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.5.9.5.2 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.5.9.5.3 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.5.9.5.4 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.5.9.5.5 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.5.9.5.6 Rest of Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
  • 13.6 South and Central America
    • 13.6.1 South and Central America Pharmacovigilance and Drug Safety Software Market Overview
    • 13.6.2 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
    • 13.6.3 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
      • 13.6.3.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Offering
    • 13.6.4 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
      • 13.6.4.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Deployment
    • 13.6.5 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
      • 13.6.5.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Enterprise Size
    • 13.6.6 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
      • 13.6.6.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Form
    • 13.6.7 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
      • 13.6.7.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Functionality
    • 13.6.8 South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.6.8.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by End User
    • 13.6.9 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.6.9.1 South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.6.9.2 Brazil: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.6.9.2.1 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.6.9.2.2 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.6.9.2.3 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.6.9.2.4 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.6.9.2.5 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.6.9.2.6 Brazil: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.6.9.3 Argentina: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.6.9.3.1 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.6.9.3.2 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.6.9.3.3 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.6.9.3.4 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.6.9.3.5 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.6.9.3.6 Argentina: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
      • 13.6.9.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast to 2031 (US$ Million)
        • 13.6.9.4.1 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
        • 13.6.9.4.2 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
        • 13.6.9.4.3 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
        • 13.6.9.4.4 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
        • 13.6.9.4.5 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by Functionality
        • 13.6.9.4.6 Rest of South and Central America: Pharmacovigilance and Drug Safety Software Market Breakdown, by End User

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning & Concentration

15. Industry Landscape

  • 15.1 Overview
  • 15.2 Market Initiative
  • 15.3 Merger and Acquisition

16. Company Profiles

  • 16.1 ArisGlobal LLC
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Max Application
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Oracle Corp
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Veeva Systems Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 ICON Plc
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Cognizant Technology Solutions Corp
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Accenture Plc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Syneos Health Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Genpact Ltd.
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 AB Cube S.A.S.
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Laboratory Corp of America Holdings
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Parexel International Corp
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Qinecsa Solutions
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments
  • 16.15 Clinevo Technologies
    • 16.15.1 Key Facts
    • 16.15.2 Business Descri
    • 16.15.3 Products and Services
    • 16.15.4 Financial Overview
    • 16.15.5 SWOT Analysis
    • 16.15.6 Key Developments

17. Appendix

  • 17.1 Word Index
  • 17.2 About the Insight Partners